Cochlear | COH - Ebitda

Aktienkurs
173.59
Täglich Wechseln
0.52 0.30%
Monatlich
-12.27%
Jährlich
-35.34%
Q1 Prognose
170.76




Ebitda Veränderung Datum
Ansell USD 185.8M 7M 2025-12
Avita Medical AUD -9.69M 12.21M 2025-12
Cochlear AUD 306.4M 13.5M 2025-12
CSL USD 3.13B 1.17B 2025-12
Fisher Paykel Healthcare NZD 364M 78.5M 2025-06
Healius AUD 74.9M 40.3M 2025-06
Integral Diagnostics AUD 46.27M 3.52M 2024-06
Mayne Pharma AUD 20.9M 5.2M 2025-06
Mesoblast USD -20.3M 2.51M 2025-12
Monash IVF AUD 30.74M 4.77M 2025-06
Nanosonics AUD 12.49M 1.13M 2025-12
Polynovo AUD 2.86M 1.12M 2024-06
Ramsay Health Care AUD 1.12B 10.6M 2025-12
Regis Healthcare AUD 70.59M 51.47M 2025-12
ResMed USD 547.48M 27.46M 2025-12
Sigma Healthcare AUD 19.96M 5.15M 2024-07
Somnomed AUD 764.45K 479.23K 2023-06
Sonic Healthcare AUD 839.07M 51.09M 2024-12
Telix Pharmaceuticals AUD 18.42M 14.82M 2025-12